Acute GVHD is a potential complication following an allogeneic stem cell transplant, where donor immune cells (the graft) mistakenly attack the recipient's healthy tissues (the host).
Common Areas Affected
Causes and Risk Factors: GVHD occurs when donor T cells recognize the recipient's cells as foreign and begin attacking them. Risk factors include:
Treatment Options: Treatment is tailored based on severity and organ involvement. Ongoing monitoring is essential.
Myth
The longer you go, the safer you are and won't get GVHD
Reality
Not always true. GVHD can develop later, and symptoms may be subtle at first.
Myth
It only affects the skin
Reality
GVHD can affect internal organs, and symptoms may not be visible
Speak up---even if the symptom feels small or vague
Keep a daily log of changes in skin, digestion, or energy levels
Ask for visuals or examples of what symptoms might look like
Don't wait for symptoms to worsen before calling your care team
Bring these to your next appointment
Is GVHD beneficial in fighting residual disease?
What are the early signs I should watch for?
How does GVHD differ from other post-transplant complications?
What are the treatment options if symptoms don't respond to steroids?
What does Long term monitoring look like?
From families who've been there
GVHD can affect internal organs, not just the skin---ask for full-body symptom education
Symptoms may appear gradually or overlap with other conditions
It's helpful to understand how GVHD presents differently in each person
Ask for links or visuals showing what skin or GI symptoms might look like